Inflammation Control

Name: Inflammation Control
Brand: Boling Vision Center

Chronic inflammation is one of the most common and most overlooked drivers of dry eye disease and ocular surface breakdown, and addressing it directly is often the key to achieving improvement that other treatments alone haven't been able to deliver.

Breaking the Cycle: Why Inflammation Control Matters

Inflammation and dry eye exist in a self-reinforcing loop. An unstable tear film irritates the ocular surface, triggering an inflammatory response; that inflammation damages the surface cells and glands responsible for producing healthy tears, which further destabilizes the tear film, which drives more inflammation. For many guests, this cycle is what's keeping their dry eye from improving despite consistent use of artificial tears and other supportive measures.

At Boling Vision Center's Cornea & Ocular Surface Center, identifying and interrupting that inflammatory cycle is a central part of how we approach dry eye and ocular surface disease. Schedule a dry eye evaluation at any of our four Northern Indiana locations and let's find out whether inflammation is at the root of what you've been experiencing.

How Inflammation Affects the Ocular Surface

The ocular surface is a sensitive, highly regulated environment. When inflammation takes hold, it affects virtually every component of the system. Inflammatory mediators damage the goblet cells that produce the mucin layer of the tear film, disrupting tear stability at its foundation. They impair meibomian gland function, reducing the quality of the lipid layer that prevents tears from evaporating too quickly.

They alter the corneal epithelium, compromising its protective barrier function and increasing surface vulnerability. And they activate nerve pathways that contribute to the discomfort, light sensitivity, and foreign body sensation that make chronic dry eye so difficult to live with. Addressing inflammation isn't just one part of dry eye treatment; for many guests, it's the part that makes everything else work.

How We Identify Ocular Surface Inflammation

Not all dry eye is equally driven by inflammation, and identifying the degree and nature of inflammatory involvement guides treatment decisions significantly.

Clinical Evaluation and Surface Staining

Vital dye staining of the cornea and conjunctiva reveals areas of surface cell damage that indicate where the tear film is failing and inflammation is taking its toll. The pattern and extent of staining help characterize the severity of surface disease and track response to treatment over time.

Tear Osmolarity Testing

Elevated tear osmolarity is both a marker and a driver of ocular surface inflammation. Testing provides an objective, reproducible measure of tear film health that helps guide the intensity of anti-inflammatory treatment and monitor progress.

Meibomian Gland Assessment

Because meibomian gland dysfunction and inflammation are so closely linked, a thorough assessment of gland structure and function, including imaging and secretion quality evaluation, is an important part of understanding the inflammatory picture in evaporative dry eye.

Slit-Lamp Examination

A detailed slit-lamp evaluation of the eyelid margins, conjunctiva, and cornea allows our providers to directly assess signs of active inflammation, including lid margin vascularity, conjunctival injection, and corneal surface irregularity.

I’ve been a patient at Boling Vision for many years. Each and every visit I’m greeted with pleasant and courteous people in every aspect. Everyone makes a visit personal and easy.

Vicki Reed

Inflammation Control Therapies

Inflammation control at Boling Vision Center is individualized and layered, drawing on a range of therapeutic options matched to each guest's specific presentation.

Prescription Topical Anti-Inflammatory Drops

Cyclosporine and lifitegrast are the two primary prescription anti-inflammatory options for dry eye disease, and both have strong clinical evidence supporting their use. They work by targeting the T-cell mediated inflammatory pathways at the ocular surface, reducing the inflammatory load and helping to restore healthier surface cell function over time.

These medications are typically used long-term, and results build gradually over the first one to three months of consistent use. They are the foundation of inflammation control for many of our dry eye guests.

Topical Corticosteroids

For acute inflammatory flares or as a short-term bridge while longer-acting therapies take effect, topical corticosteroids can provide rapid, meaningful relief. Because of their side effect profile with prolonged use, they are typically prescribed for defined short courses rather than ongoing maintenance, and their use is monitored carefully.

Addressing Meibomian Gland Inflammation

For guests whose inflammation is centered at the eyelid margins and meibomian glands, targeted gland treatments, including thermal expression and intense pulsed light therapy, address the inflammatory drivers of evaporative dry eye at their source. These in-office treatments complement topical therapies and can produce lasting improvements in gland function and tear film quality.

Eyelid Hygiene and Blepharitis Management

Bacterial biofilm and Demodex infestation at the lid margins are a common source of chronic low-grade inflammation that perpetuates dry eye and meibomian gland dysfunction. Targeted eyelid hygiene treatments reduce that inflammatory burden and create a cleaner lid margin environment that supports the effectiveness of other therapies.

Celluma Low-Level Light Therapy

Celluma's red and near-infrared wavelengths have documented anti-inflammatory effects at the cellular level, supporting the reduction of periocular inflammation and complementing other inflammation control strategies as part of a broader treatment plan.

Dietary and Lifestyle Support

Omega-3 fatty acid supplementation has meaningful anti-inflammatory effects relevant to dry eye disease, and there is good clinical evidence supporting its use as an adjunct to other treatments. At Boling Vision Center, we discuss nutritional and lifestyle factors as part of the overall inflammation management conversation, recognizing that what happens outside the eye matters too.

What to Expect from Inflammation Control Treatment

Inflammation control is not a quick fix, and setting realistic expectations is an important part of the process. Prescription anti-inflammatory drops typically take one to three months to produce their full benefit, and the most significant improvements often come from sustained, consistent treatment rather than short courses.

That said, most guests who follow a targeted inflammation control plan see meaningful improvement in both symptoms and measurable markers of ocular surface health over time. Regular follow-up allows us to track progress, adjust the plan as needed, and ensure that treatment continues to be matched to where things stand.

Schedule A Consultation

Why Choose Boling Vision Center?

At Boling Vision Center's Cornea & Ocular Surface Center, inflammation control is approached with the same diagnostic precision and clinical depth we bring to every aspect of dry eye care. We don't guess at what's driving a guest's condition; we evaluate it thoroughly and treat it specifically. With four Northern Indiana locations, advanced diagnostics, and a full range of therapeutic options, we're equipped to address even the most persistent ocular surface inflammation. Amazing happens here.

Frequently Asked Questions Inflammation Control

How do I know if inflammation is driving my dry eye?

A comprehensive dry eye evaluation, including tear osmolarity testing, surface staining, and meibomian gland assessment, gives us a detailed picture of the role inflammation is playing in your condition. Many guests who come to us after years of using drops without adequate relief find that inflammation has been the missing piece in their treatment picture.

Are prescription anti-inflammatory eye drops safe for long-term use?

Yes. Cyclosporine and lifitegrast have well-established long-term safety profiles and are designed for ongoing use in chronic dry eye disease. Unlike corticosteroids, they do not carry risks of elevated intraocular pressure or cataract formation with prolonged use, making them appropriate for sustained treatment.

Can I use anti-inflammatory drops if I also use artificial tears?

Yes, and most guests do. Preservative-free artificial tears can be used alongside prescription anti-inflammatory drops. Your provider will advise on timing, as it's generally recommended to wait a few minutes between different eye drops to allow each to be absorbed properly.

How long do I need to stay on anti-inflammatory treatment?

For many guests with chronic dry eye disease, ongoing anti-inflammatory treatment is part of long-term management rather than a time-limited course. Others may be able to step down to a maintenance approach after achieving a stable improvement. Your provider will guide that decision based on how your ocular surface responds over time.

Will treating inflammation cure my dry eye?

Inflammation control is a critical component of dry eye treatment for many guests, but dry eye is often multifactorial, meaning inflammation is one of several drivers that need to be addressed. Treating it effectively can produce dramatic improvements, but the most complete and lasting results typically come from a comprehensive plan that addresses all the relevant mechanisms together.